Table 1 Distributions of OPNI according to clinical features.
clinical features | cases (n = 108) | OPNI | P | clinical features | cases (n = 108) | OPNI | P |
|---|---|---|---|---|---|---|---|
Gender | >0.05 | PL | >0.05 | ||||
Male | 67 | 38.8 ± 8.0 | L1 + L2 | 50 | 39.5 ± 9.4 | ||
Female | 41 | 39.8 ± 8.9 | L3 | 58 | 38.5 ± 7.0 | ||
Age(y) | >0.05 | DT | <0.05 | ||||
≤40(A1 + A2) | 62 | 38.5 ± 8.4 | B1 + B2 | 72 | 41.2 ± 8.1 | ||
>40(A3) | 46 | 37.5 ± 8.6 | B3 | 36 | 36.5 ± 7.7 | ||
SH | >0.05 | POD (y) | >0.05 | ||||
NO | 76 | 39.7 ± 9.2 | ≤1 | 60 | 39.3 ± 8.2 | ||
YES | 38 | 37.9 ± 5.6 | 1 < n ≤ 3 | 22 | 38.3 ± 9.7 | ||
HA | >0.05 | 3 < n ≤ 5 | 9 | 38.4 ± 7.1 | |||
NO | 83 | 38.2 ± 8.7 | 5 < n ≤ 10 | 15 | 39.5 ± 7.2 | ||
YES | 25 | 42.6 ± 6.0 | >10 | 2 | 49.6 ± 11.2 | ||
EO | >0.05 | PNC | >0.05 | ||||
NO | 81 | 41.5 ± 6.8 | Normal | 92 | 38.6 ± 8.5 | ||
YES | 27 | 32.2 ± 8.6 | Higher | 16 | 39.7 ± 6.9 | ||
BT | >0.05 | PLC | <0.05 | ||||
A+ | 27 | 39.3 ± 7.6 | Normal | 79 | 41.3 ± 6.7 | ||
B+ | 32 | 38.3 ± 9.6 | Lower | 29 | 32.1 ± 8.4 | ||
O+ | 36 | 39.3 ± 8.0 | PH | <0.05 | |||
AB+ | 12 | 41.2 ± 8.1 | Normal | 31 | 44.8 ± 7.5 | ||
EM | >0.05 | Lower | 77 | 36.9 ± 7.6 | |||
NO | 81 | 39.0 ± 9.1 | PPA | <0.05 | |||
YES | 27 | 39.7 ± 5.6 | Normal | 28 | 45.1 ± 5.3 | ||
PL | >0.05 | Lower | 80 | 37.1 ± 8.2 | |||
NO | 94 | 38.8 ± 8.6 | PA | <0.05 | |||
YES | 14 | 41.8 ± 5.6 | Normal | 49 | 45.3 ± 4.3 | ||
p-BMI | >0.05 | Lower | 59 | 33.4 ± 6.7 | |||
<18.5 | 69 | 38.9±9.0 | PEN | <0.05 | |||
≥18.5 | 39 | 38.6 ± 6.6 | EN | 62 | 42.7 ± 6.6 | ||
NO EN | 46 | 35.0 ± 8.7 |
